India to Venezuela: Digoxin Export Trade Route
India has recorded 29 verified shipments of Digoxin exported to Venezuela, representing a combined trade value of $115.9K USD. This corridor is served by 15 active Indian exporters, with an average shipment value of $4.0K USD. The leading Indian exporter is LIVEALTH BIOPHARMA PRIVATE LIMITED, which accounts for 23% of total export value with 2 shipments worth $26.3K USD. On the buying side, TO THE ORDER OF is the largest importer in Venezuela with $35.6K USD in purchases. The top 3 suppliers — LIVEALTH BIOPHARMA PRIVATE LIMITED, BETA DRUGS LIMITED, S D PHARMACEUTICALS — together control 60% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Venezuela Digoxin corridor is one of India's established pharmaceutical export routes, with 29 shipments documented worth a combined $115.9K USD. The route is dominated by LIVEALTH BIOPHARMA PRIVATE LIMITED, which alone accounts for roughly 23% of all export value, reflecting the consolidated nature of India's digoxin manufacturing sector.
Across 15 active suppliers, the average shipment value stands at $4.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (60%) and air (40%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October-December, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 5%, placing it at rank #15 among India's top digoxin export destinations globally.
On the import side, key buyers of Indian digoxin in Venezuela include TO THE ORDER OF, LEBOO HEALTHCARE PRODUCTS C.A, FARMAUNTENTICA 2021 C A and 12 others. TO THE ORDER OF is the single largest importer with 5 shipments valued at $35.6K USD.
